Lymphoma, T-Cell, Cutaneous | Mycosis Fungoides | Mycosis fungoides stage I | Mycosis fungoides stage II
Item
subjects must have a clinical diagnosis of ctcl (mycosis fungoides), stage ia, stage ib, or stage iia.
boolean
C0079773 (UMLS CUI [1])
C0026948 (UMLS CUI [2])
C0278567 (UMLS CUI [3])
C0278569 (UMLS CUI [4])
Lesion Separate | Minimum Three
Item
subjects must have a minimum of three (3) evaluable, discrete lesions.
boolean
C0221198 (UMLS CUI [1,1])
C0443299 (UMLS CUI [1,2])
C1524031 (UMLS CUI [2,1])
C0205449 (UMLS CUI [2,2])
Willing Abstinence Sunbathing
Item
subjects must be willing to refrain from sunbathing for the duration of the study.
boolean
C0600109 (UMLS CUI [1,1])
C3843422 (UMLS CUI [1,2])
C0038813 (UMLS CUI [1,3])
Hypersensitivity Sunlight | Dermatitis, Phototoxic | Porphyria | Lupus Erythematosus, Systemic | Sjogren's Syndrome | Xeroderma Pigmentosum | Melanoma | Therapeutic procedure Polymorphous light eruption | Therapeutic radiology procedure
Item
history of sun hypersensitivity and photosensitive dermatoses including porphyria, systemic lupus erythematosus, sjögren's syndrome, xeroderma pigmentosum, and melanoma, or polymorphous light or radiation therapy within 30 days of enrolling.
boolean
C0020517 (UMLS CUI [1,1])
C0038817 (UMLS CUI [1,2])
C0162830 (UMLS CUI [2])
C3463940 (UMLS CUI [3])
C0024141 (UMLS CUI [4])
C1527336 (UMLS CUI [5])
C0043346 (UMLS CUI [6])
C0025202 (UMLS CUI [7])
C0087111 (UMLS CUI [8,1])
C0031736 (UMLS CUI [8,2])
C1522449 (UMLS CUI [9])
Pregnancy | Breast Feeding
Item
pregnancy or mothers who are breast feeding.
boolean
C0032961 (UMLS CUI [1])
C0006147 (UMLS CUI [2])
Unwilling Contraceptive methods
Item
males and females not willing to use effective contraception.
boolean
C0558080 (UMLS CUI [1,1])
C0700589 (UMLS CUI [1,2])
Sunburn Healed
Item
unhealed sunburn.
boolean
C0038814 (UMLS CUI [1,1])
C0205249 (UMLS CUI [1,2])
systemic steroids | Topical steroids | Mechlorethamine | PUVA Photochemotherapy | Carmustine | Systemic therapy Lymphoma, T-Cell, Cutaneous
Item
subjects receiving systemic or topical steroids, nitrogen mustard, psoralen uva radiation therapy (puva), or carmustine (bcnu) or other systemic therapies for ctcl within 3 weeks of enrollment.
boolean
C2825233 (UMLS CUI [1])
C2064827 (UMLS CUI [2])
C0025033 (UMLS CUI [3])
C0853073 (UMLS CUI [4])
C0007257 (UMLS CUI [5])
C1515119 (UMLS CUI [6,1])
C0079773 (UMLS CUI [6,2])
Decreased Immunologic Activity Due to Pharmaceutical Preparations | Decreased Immunologic Activity Due to HIV Infections | Decreased Immunologic Activity Due to Human T-lymphotropic virus 1
Item
subjects with significant history of systemic immunosuppression due to drugs or infection with hiv or htlv 1.
boolean
C1373218 (UMLS CUI [1,1])
C0678226 (UMLS CUI [1,2])
C0013227 (UMLS CUI [1,3])
C1373218 (UMLS CUI [2,1])
C0678226 (UMLS CUI [2,2])
C0019693 (UMLS CUI [2,3])
C1373218 (UMLS CUI [3,1])
C0678226 (UMLS CUI [3,2])
C0020094 (UMLS CUI [3,3])
Investigational New Drugs Other | Drug abuse
Item
subjects taking other investigational drugs or drugs of abuse within 30 days of entry into this study.
boolean
C0013230 (UMLS CUI [1,1])
C0205394 (UMLS CUI [1,2])
C0013146 (UMLS CUI [2])